Patent US6607736B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6607736B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Skin preparations for external use

Assignee: Shiseido Co Ltd
•
Filing: 2000-12-19
•
Granted: 2003-08-19
•
Expires: 2020-12-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An endermic liniment comprising a polyoxyethylene dicarboxylate represented by the following chemical formula (1). (In this formula, R1 and R2 are hydrogen or alkyl or branched alkyl groups having 1-4 carbon atoms, and m, n, X, and Y are integers 0-5 which are not all zero at the same time. R3 is a branched or linear chain alkylene group having 0-10 carbon atoms.) The endermic liniment of the present invention achieves superior tactile sensation during use, smoothness in particular, without a sticky sensation, while maintaining a lasting moisture retaining effect by means of blending in a humectant and a polyoxyethylene dicarboxylate.

Inventors

  • 👤 Takashi Ohmori
  • 👤 Reiji Miyahara
  • 👤 Hiroyuki Kakoki
  • 👤 Tomiyuki Namba

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 06:40
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/33; A61K8/36; A61K8/362; A61K8/39; A61K8/72; A61K8/84; A61Q; A61Q19/00; A61Q19/02; A61Q1/00; A61Q1/02

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 74 words
An endermic liniment consisting essentially of a polyoxyethylene dicarboxylate represented by the following chemical formula (1), wherein R1 and R2 are hydrogen or alkyl or branched alkyl groups having 1-4 carbon atoms, and m, n, X, and Y are integers 0-5 which are not all zero at the same time, R3 is a branched or linear chain alkylene group having 0-10 carbon atoms, and a humectant, wherein the polyoxyethylene dicarboxylate is diethoxy ethyl succinate.
Claim 2
Dependent Claim 74 words
An endermic liniment consisting essentially of a polyoxyethylene dicarboxylate represented by the following chemical formula (1), wherein R1 and R2 are hydrogen or alkyl or branched alkyl groups having 1-4 carbon atoms, and m, n, X, and Y are integers 0-5 which are not all zero at the same time, R3 is a branched or linear chain alkylene group having 0-10 carbon atoms, and a humectant, wherein the polyoxyethylene dicarboxylate is diethoxy ethyl succinate.
Claim 3
Dependent Claim 63 words
The endermic liniment of claim 1 , wherein the humectant is selected from the group consisting of polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, inucoitin sulfuric acid, charonic acid, atelocollagen, cholesteryl-12-hydroxy stearate, sodium lactate, bile salt, di-pyrrolidone carboxylic acid salt, short chain soluble collagen, diglycerin (EO)PO adduct, chestnut rose extract, yarrow extract, and sweet clover extract.
Claim 4
Dependent Claim 124 words
An endermic liniment consisting essentially of: diethoxy ethyl succinate; a humectant selected from the group consisting of polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfuric acid, charonic acid, atelocollagen, cholesteryl-12-hydroxy stearate, sodium lactate, bile salt, di-pyrrolidone carboxylic acid salt, short chain soluble collagen, diglycerin (EO)PO adduct, chestnut rose extract, yarrow extract, and sweet clover extract; and one or more whitening agents selected from the group consisting of L-ascorbic acid, L-ascorbyl alkyl ester, L-ascorbyl phosphate, L-ascorbyl sulfate, alkali metal salts thereof, alkaline earth metal salts thereof, kojic acid, kojic esters, kojic ethers, a glucoside of hydroquinone, hexose glucosides, pentose glucosides, amino acid glucosides, uronic acid glucosides, esters of uronic acid glucosides, and ethers of uronic acid glucosides.
Claim 5
Dependent Claim 124 words
An endermic liniment consisting essentially of: diethoxy ethyl succinate; a humectant selected from the group consisting of polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfuric acid, charonic acid, atelocollagen, cholesteryl-12-hydroxy stearate, sodium lactate, bile salt, di-pyrrolidone carboxylic acid salt, short chain soluble collagen, diglycerin (EO)PO adduct, chestnut rose extract, yarrow extract, and sweet clover extract; and one or more whitening agents selected from the group consisting of L-ascorbic acid, L-ascorbyl alkyl ester, L-ascorbyl phosphate, L-ascorbyl sulfate, alkali metal salts thereof, alkaline earth metal salts thereof, kojic acid, kojic esters, kojic ethers, a glucoside of hydroquinone, hexose glucosides, pentose glucosides, amino acid glucosides, uronic acid glucosides, esters of uronic acid glucosides, and ethers of uronic acid glucosides.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2006-08-18 2007-02-17 2007-08-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2010-08-18 2011-02-17 2011-08-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2014-08-18 2015-02-17 2015-08-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag